Alphyn Biologics

Clinical-stage dermatology co. developing first-in-class Multi-Target Therapeutics (MTT)

Based in MD

🤖

AI Overview

With $30K in lobbying spend across 3 quarterly filings, Alphyn Biologics is an active lobbying client. Their lobbying covers 2 issue areas.

$30K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$30K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Alphyn Biologics disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED

Issues related to the development of biologic therapies before Congress, the Food and Drug Administration (FDA), and other federal health agencies.

Advocacy work around Atopic Dermatitis (eczema).

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.